Managing Asthma in Pregnancy (MAP) Study

Not Applicable

Completed

• Conditions: Asthma control during pregnancy; Respiratory - Asthma

• Registration Number: ACTRN12607000561482
• Lead Sponsor: Hunter New England Health

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2007-11-01
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 210

Inclusion Criteria

12-20 weeks gestation
Doctor diagnosis of asthma
Symptoms of asthma or taken treatment for asthma in the last 12 months

Exclusion Criteria

Concomittent chronic medical illness,
chronic lung disease other than asthma, drug or alcohol dependence,
inability to attend study visits,
inability to perform spirometry,
>3 courses of oral corticoseroids (OCS) in past year,
Hospital admission for an asthma exacerbation in the past 3 months,
on regular oral prednisolone or theophylline

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Asthma exacerbations[Total number of exacerbations at end of pregnancy. Measured by monthly visits, fortnightly phonecalls and extra home or hospital visits in between these times if an exacerbation occurs]

Secondary Outcome Measures

Name	Time	Method
Short-acting beta-agonist use, inhaled corticosteroid (ICS) dose, quality of life, psychological varaiables, FENO, adherence to medication, birthweight, gestational age[Short-acting beta-agonist use & ICS dose recorded monthly, quality of life and psycohological variables recorded at baseline, 1 month, 2months and 4 months]